喘试验中的运行期和治疗结果:叙述性综述
Emilio Pizzichini1,2, Guy Brusselle3, Dawn Edwards1
1GSK, London, UK.
Contemporary clinical trials communications
|December 10, 2024
概括
喘试验中的运行期设计显著影响结果. 运行变化的标准化报告对于区分治疗效益与改善坚持和比较临床试验数据至关重要.
科学领域:
- 临床试验 临床试验
- 呼吸系统医学 呼吸系统医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 运行期是随机对照试验的关键组成部分,特别是在呼吸系统疾病研究中.
- 运行期的设计可以大大影响研究结果和结果的解释.
研究的目的:
- 审查六项评估喘三重治疗的3a期试验中运行期的设计.
- 讨论如何运行期的持续时间,治疗和报告的变化可能会影响研究结果的解释.
主要方法:
- 分析了6项3a期喘试验的运行期设计.
- 检查运行持续时间,治疗策略,并报告随机化前变化.
主要成果:
- 试行期从2周到7周不等,一些试验包括查和稳定阶段.
- 运行治疗包括继续先前的治疗或调整到特定的吸入性皮质类固醇/长效β2激动剂 (ICS/LABA) 组合.
- 大多数研究没有报告在运行阶段观察到的变化.
结论:
- 应有意地设计运行期,以与特定的研究目标保持一致.
- 建议对运行期变化进行标准化报告,以区分坚持改善与真正的治疗效果,并促进跨试验的数据比较.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists
233
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
233
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
218
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
218
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349


